Cyclooxygenase-2 expression in feline pancreatic adenocarcinomas

Journal of Veterinary Diagnostic Investigation

Volumn 18, Issue 6, 2006, Pages 590-593

  Newman, Shelley Joy ^a   Mrkonjich, Ladonna ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Carcinoma; Cyclooxygenase; Feline; Neoplasia; Pancreas

Indexed keywords

ANIMALIA; FELIDAE;

EID: 33751106126     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870601800612     Document Type: Article

References (22)

1. Beam SL, Rassnick KM, Moore AS, McDonough SP: 2003, An immunohistochemical study of cyclo-oxygenase-2 expression in various feline neoplasms. Vet Pathol 40:496-500.
2. Benitah SA, Valeron PF, Lacal JC: 2003, ROCK and nuclear factor-kappa B-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell 14:3041-3054.
3. Borzacchiello G, Paciello O, Papparella S: 2004, Expression of cyclo-oxygenase-1 and -2 in canine nasal carcinomas. J Comp Pathol 131:70-76.
4. Dore M, Lanthier I, Sirois J: 2003, Cyclooxygenase-2 expression in canine mammary tumors. Vet Pathol 40:207-212.
5. Franco L, Doria D, Bertazzoni E, et al.: 2004, Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. Prostaglandins Other Lipid Mediat 73:51-58.
6. Heller DA, Clifford CA, Goldschmidt MH, et al.: 2005, Assessment of cyclo-oxygenase-2 expression in canine hemangiosarcoma, histiocyte sarcoma and mast cell tumor. Vet Pathol 42:350-353.
7. Heller DA, Clifford CA, Goldschmidt MH, et al.: 2005, Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma. Vet Pathol 42:776-780.
8. Kahn KN, Knapp DW, Denicola DB, Harris RK: 2000, Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Am J Vet Res 61:478-481.
9. Kahn KN, Stanfield KM, Trajkovic D, Knapp DW: 2001, Expression of cyclooxygenase-2 in canine renal cell carcinoma. Vet Pathol 38:116-119.
10. Kleiter M, Malarkey DE, Ruslander DE, Thrall DE: 2004, Expression of cyclooxygenase-2 in canine epithelial nasal tumors. Vet Radiol Ultrasound 45:255-260.
11. Kong G, Kim EK, Kim WS, et al.: 2002, Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer. J Gastroenterol Hepatol 17:914-921.
12. Maitra A, Ashfaq R, Gunn CR: 2002, Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Am J Clin Pathol 118:194-201.
13. Mayr B, Schaffner G, Reifinger M, Loupal G: 2003, K-ras protooncogene mutations in feline pancreatic adenocarcinomas. Vet Rec 153:468-469.
14. McEntee MF, Cates JM, Neilsen N: 2002, Cyclooxygenase-2 expression in spontaneous intestinal neoplasia in domestic dogs. Vet Pathol 39:428-436.
15. Mohammed SI, Khan KN, Sellers RS, et al.: 2004, Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids 70:479-483.
16. Mullins MN, Lana SE, Dernell WS, et al.: 2004, Cyclooxygenase-2 expression in canine appendicular osteosarcomas. J Vet Intern Med 18:859-865.
17. Pestili de Almeida EM, Piche C, Sirois J, Dore M: 2001, Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. J Histochem Cytochem 49:867-875.
18. Queiroga FL, Perez-Alenza MD, Silvan G: 2005, Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance. Anticancer Res 25:4269-4275.
19. Seaman RL: 2004, Exocrine pancreatic neoplasia in the cat: a case series. J Am Anim Hosp Assoc 40:238-245.
20. Spugnini EP, Porrello A, Citro G, Baldi A: 2005, COX-2 overexpression in canine tumors: potential therapeutic targets in oncology. Histol Histopathol 20:1309-1312.
21. Wang Hx, Chen QK: 2003, Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas. Ai Zheng 22:649-652.
22. Yip-Schneider MT, Barnard DS, Billings SD: 2000, Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis 21:139-146.